Single-shot Turbo Spin-echo Diffusion-weighted Imaging for Retinoblastoma: Initial Experience
Overview
Authors
Affiliations
Background And Purpose: Retinoblastoma may exhibit variable hyperintensities on DWI, resulting in different values in the ADC maps, depending on their histology and cellularity. However, EP-based DWI has susceptibility artifacts and image distortions, which make DWI of the orbit a challenging technique. The aim of this study was to investigate the feasibility of single-shot turbo spin-echo (HASTE) DWI in the evaluation of children with retinoblastoma and to assess the value of ADC maps in differentiating viable and necrotic tumor tissue.
Materials And Methods: Two radiologists assessed conventional MR images, DWI, and ADC maps of 17 patients with retinoblastoma (n = 17 eyes). Non-EP DWI was performed by using a HASTE sequence with b-values of 0 and 1000 s/mm(2). ADC values were measured for enhancing and nonenhancing tumor tissue. ADC maps were compared with histopathologic findings regarding tumor differentiation and viability.
Results: On DWI, vital tumor tissue showed hyperintensity with negligible intensity of surrounding vitreous. The difference in mean (range) ADC values between enhancing (1.03 [0.72-1.22] × 10(-3) mm(2) s(-1)) and nonenhancing (1.47 [0.99-1.80] × 10(-3) mm(2) s(-1)) parts of retinoblastoma was statistically significant (P < .0005). Nonenhancing tumor parts showed a significantly lower ADC compared with vitreous (2.67 [2.24-3.20]×10(-3) mm(2) s(-1)) (P < .0005) and subretinal fluid (2.20 [1.76-2.96] × 10(-3) mm(2) s(-1)) (P < .0005). Histopathologically, low ADC values (enhancing tumor part) correlated to viable tumor tissue, whereas intermediate ADC values (nonenhancing tumor parts) correlated to necrotic tumor tissue.
Conclusions: HASTE DWI allowed adequate characterization of retinoblastoma, and ADC is a helpful tool to differentiate viable and necrotic tumor tissue and might be valuable in monitoring the response to eye-preserving therapies.
Role of apparent diffusion map in the evaluation of retinoblastoma.
Spadoni V, Conceicao T, Schaefer F, Ercolani D, Maestri M, Klaes A Arq Bras Oftalmol. 2024; 87(2):e20210435.
PMID: 38422355 PMC: 11575744. DOI: 10.5935/0004-2749.2021-0435.
Sharma M, Gupta A, Jana M, Kashyap S, Bakhshi S, Sharma S AJNR Am J Neuroradiol. 2024; 45(2):198-204.
PMID: 38176729 PMC: 11285979. DOI: 10.3174/ajnr.A8084.
Jaarsma-Coes M, Klaassen L, Marinkovic M, Luyten G, Vu T, Ferreira T Cancers (Basel). 2023; 15(11).
PMID: 37296958 PMC: 10252038. DOI: 10.3390/cancers15112995.
A descriptive neuroimaging study of retinoblastoma in children: magnetic resonance imaging features.
Orman G, Huisman T Pol J Radiol. 2022; 87:e363-e368.
PMID: 35979155 PMC: 9373869. DOI: 10.5114/pjr.2022.118107.
Ogawa M, Urano M, Takaishi T, Kan H, Arai N, Takahashi H PLoS One. 2021; 16(4):e0249433.
PMID: 33882087 PMC: 8059798. DOI: 10.1371/journal.pone.0249433.